🎤 Cheer for Your Idol · Gate Takes You Straight to Token of Love! 🎶
Fam, head to Gate Square now and cheer for #TokenOfLove# — 20 music festival tickets are waiting for you! 🔥
HyunA / SUECO / DJ KAKA / CLICK#15 — Who are you most excited to see? Let’s cheer together!
📌 How to Join (the more ways you join, the higher your chance of winning!)
1️⃣ Interact with This Post
Like & Retweet + vote for your favorite artist
Comment: “I’m cheering for Token of Love on Gate Square!”
2️⃣ Post on Gate Square
Use hashtags: #ArtistName# + #TokenOfLove#
Post any content you like:
🎵 The song you want to he
BioNTech rose about 8.5% after reaching a licensing protocol worth over $11 billion with Bristol-Myers Squibb.
Golden Ten Data reported on June 3 that BioNTech SE (BNTX.O) continued to rise about 8.5% to $122.7. The stock rose more than 18% yesterday. On the news side, Squibb announced that it has reached a licensing agreement with BioNTech for a new generation of anti-cancer drug BNT327, with milestone payments of up to $11.1 billion. Truist Securities raised its price target on BioNTech to $155 from $151, maintaining a "buy" rating.